| Followers | 200 |
| Posts | 25557 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Sunday, October 06, 2024 2:06:09 PM
Clinics in Germany can individually do all kinds of nonsense and sell it. They have a special exemption which I is one doctor or one clinic and their patient. It’s not a commercial thing and no, they do not have the specific process of DCVax-L, and yeah, cell therapies can be mimicked and pretend copied. But that one and none of the others is licensed for commercial sale or distribution after clinical trials in any major country.
You overstate the claim to suggest something that is garbage. But you know retail newbies won’t know you’re saying garbage and superficial web searches or other nonsense will lead them down your false trail.
And that is literally all you do. It’s your job to lead people, apparently, down false trail so that you can profit off of shorting small, innovative companies.
You’re not a lot better than an arsonist in that context.
And let me quickly also clarify on that clinic in Germany, they make all kinds of claims and throw every buzzword at their vaccine, that is used viruses and dendritic cells and immune therapies. Those clinics are for the desperate with cash and yeah, not saying they’re a complete fraud but they are not for commercialized drugs either. They are for a rich person to go and at least believe they are getting the latest, unproven, experimental treatments. Whether that is true or not is really never validated. It’s desperation that drives people to those clinics. I have friends who have gone to such, none ever with successful results.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
